AzTrials
AzTrials

Groin HerniaPhase 4NCT05934266

Impact of Mesh Fixation With Tissue Adhesive

A Phase 4 study testing Use of n-hexyl cyanoacrylate for mesh fixation in people with Groin Hernia and Hernia, Inguinal, run by Hospital Universitario de Móstoles at 1 site in Spain.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Randomized controlled trial on mesh fixation using cyanoacrylate glue compared to standard suture in open inguinal hernia repair. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Groin Hernia, Hernia, Inguinal, Postoperative Pain
What is being tested?
Use of n-hexyl cyanoacrylate for mesh fixation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
160 participants
Where
1 siteSpain
Study dates
29 Mar 2023to 29 May 2026
Phase
Phase 4
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Elective open inguinal hernioplasty in patients over 18 years old

Who cannot join

  • Patient refusal
  • Laparoscopic surgery
  • Reintervention surgery
  • Urgent surgery
  • Cyanoacrylate allergy
  • Administration of intraoperative local anesthetics
  • Comorbidities that may affect the requirements of analgesics, such as degenerative arthropathies, fibromyalgia, etc.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Hospital Universitario de Móstoles

    Móstoles, Madrid

Other trials in Spain

About this study

Official title: Impact of Mesh Fixation With Tissue Adhesive on Open Inguinal Hernia Repair

Randomized controlled trial on mesh fixation using cyanoacrylate glue compared to standard suture in open inguinal hernia repair.

Read the detailed description

Hernioplasty with suture-fixed mesh is the standard technique for the treatment of inguinal hernia, one of the most frequent pathologies in the Surgery Service. Despite its good results in terms of recurrences, it is currently under review due to the incidence of chronic postoperative pain. Up to half of the patients report some type of pain at one year of follow-up, and 15% report moderate-severe pain.

The objective of the study is to analyze whether the use of tissue adhesive (n-hexyl cyanoacrylate 0.5 ml) for mesh fixation in patients undergoing scheduled open inguinal hernioplasty results in a better postoperative evolution, with less chronic pain and less demand for analgesia, compared with a control group of patients who undergo the same surgical intervention with standard suture repair.

Being tested
Use of n-hexyl cyanoacrylate for mesh fixation
Keywords
hernioplasty, mesh fixation, n-hexyl cyanoacrylate, groin hernia, postoperative pain
Medical subject headings
Hernia, Inguinal, Pain, Postoperative, Neuralgia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Use of n-hexyl cyanoacrylate for mesh fixationDevice

    Mesh fixation with tissue adhesive (n-hexyl cyanoacrylate) in open hernia repair

Study groups in NCT05934266
Study groupRoleWhat they receive
Tissue adhesiveExperimentalGroup of 80 patients in which mesh fixation is done using cyanoacrylate glue
Receives: Device: Use of n-hexyl cyanoacrylate for mesh fixation
Standard sutureNo interventionGroup of 80 patients who undergo hernioplasty with standard suture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative pain assessed by visual numeric scale

    Values come from 0 to 10, where 0 means no pain and 10 means the worst imaginable pain.

    Measured: 6 months

  2. Postoperative administration of analgesics

    Record of dose of analgesics needed: nonsteroidal anti-inflamatory drugs, opioid requirements, other analgesics requirements

    Measured: 6 months

Secondary outcomes (2)
  1. Hernia recurrence

    Hernia recurrence rate after mesh fixation with tissue adhesive

    Measured: 6 months

  2. Hematoma

    Groin hematoma following hernioplasty with n-hexyl cyanoacrylate

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jul 2023
  2. Study start29 Mar 2023
  3. Primary completion1 May 2025
  4. Study completion29 May 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
160 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05934266
Sponsor's protocol ID
HUMostoles
Status last verified
May 2025
First submitted
12 Jun 2023
Last updated
2 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All IPD that underlie results in a publication

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Use of n-hexyl cyanoacrylate for mesh fixation in people with Groin Hernia and Hernia, Inguinal, run by Hospital Universitario de Móstoles at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 2 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative pain assessed by visual numeric scale (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in